← Oncology Approval Tracker

FDA DECISION ·

Keytruda

pembrolizumab · Merck

FDA approvalNew or expanded indicationHead and neck squamous cell carcinoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

For adults with resectable locally advanced head and neck squamous cell carcinoma with PD-L1 CPS of at least 1 on an FDA-approved test. Pembrolizumab is given before surgery, with adjuvant radiotherapy with or without cisplatin, then alone.

LAMPGEN ANALYSIS

Why it matters

The approval established a perioperative PD-1 regimen in PD-L1-positive, resectable locally advanced head and neck cancer.

What research teams should watch

Arrange PD-L1 testing before surgery and protect the handoff between surgery, radiation, and systemic treatment.

PRIMARY RECORDS

Sources